JP2023549394A5 - - Google Patents
Info
- Publication number
- JP2023549394A5 JP2023549394A5 JP2023528637A JP2023528637A JP2023549394A5 JP 2023549394 A5 JP2023549394 A5 JP 2023549394A5 JP 2023528637 A JP2023528637 A JP 2023528637A JP 2023528637 A JP2023528637 A JP 2023528637A JP 2023549394 A5 JP2023549394 A5 JP 2023549394A5
- Authority
- JP
- Japan
- Prior art keywords
- adhd
- compound
- use according
- administered
- interventions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2017858.8A GB202017858D0 (en) | 2020-11-12 | 2020-11-12 | Novel treatments |
| GB2017858.8 | 2020-11-12 | ||
| GBGB2103400.4A GB202103400D0 (en) | 2021-03-11 | 2021-03-11 | Novel treatments |
| GB2103400.4 | 2021-03-11 | ||
| PCT/EP2021/081567 WO2022101435A1 (en) | 2020-11-12 | 2021-11-12 | Novel treatments of attention deficit/hyperactivity disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549394A JP2023549394A (ja) | 2023-11-24 |
| JP2023549394A5 true JP2023549394A5 (cg-RX-API-DMAC7.html) | 2024-11-19 |
Family
ID=78649316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023528637A Pending JP2023549394A (ja) | 2020-11-12 | 2021-11-12 | 注意欠陥/多動性障害の新規な治療 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240002369A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4243826A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023549394A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022101435A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023084054A1 (en) * | 2021-11-12 | 2023-05-19 | 3Z Ehf | Treatment of adhd using selective binders of the 11-imidazoline receptor |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3236857A (en) * | 1961-10-09 | 1966-02-22 | Boehringer Sohn Ingelheim | 2-(phenyl-amino)-1, 3-diazacyclopentene-(2) substitution products |
| DE2849537C2 (de) * | 1978-11-15 | 1983-03-17 | Beiersdorf Ag, 2000 Hamburg | Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| US4323570A (en) | 1978-11-15 | 1982-04-06 | Beiersdorf Aktiengesellschaft | Substituted aminopyrimidines |
| MA18829A1 (fr) * | 1979-05-18 | 1980-12-31 | Ciba Geigy Ag | Derives de la pyrimidine,procedes pour leur preparation,compositions pharmaceutiques contenant ces composes et leur utilisation therapeutique |
| NO980546L (no) * | 1997-02-11 | 1998-08-12 | Lilly Co Eli | Farmas°ytiske midler |
| CA2427900A1 (en) * | 2000-11-14 | 2002-05-23 | F. Hoffmann-La Roche Ag | Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists |
| AU2003251949A1 (en) * | 2002-07-18 | 2004-02-09 | Vanderbilt University | Therapeutic and screening methods employing partial agonism of the alpha-2a adrenergic receptor subtype |
| JP2009524619A (ja) * | 2006-01-27 | 2009-07-02 | エフ.ホフマン−ラ ロシュ アーゲー | Cns障害の処置のための2−イミダゾールの使用 |
-
2021
- 2021-11-12 EP EP21810016.2A patent/EP4243826A1/en not_active Withdrawn
- 2021-11-12 WO PCT/EP2021/081567 patent/WO2022101435A1/en not_active Ceased
- 2021-11-12 US US18/316,131 patent/US20240002369A1/en not_active Abandoned
- 2021-11-12 JP JP2023528637A patent/JP2023549394A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7033642B2 (ja) | 選択的s1p1レセプターアゴニストを含む薬学的合剤 | |
| AU2007213194B9 (en) | Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3-propanaediol derivative as active ingredient, and method for treatment of inflammatory bowel disease | |
| RU2478384C2 (ru) | Курс лечения с использованием агониста рецептора s1p | |
| US20090023712A1 (en) | Pharmaceutical Compositions for the Treatment of Attention Deficit Hyperactivity Disorder Comprising Flibanserin | |
| US20060258640A1 (en) | Use of Flibanserin in the treatment of chronic pain | |
| RU2009102278A (ru) | Модуляторы рецептора s1p для лечения рассеянного склероза | |
| EP1858516A1 (en) | Pharmaceutical compositions for the treatment and/or prevention of depression | |
| RU2011129856A (ru) | Схема приема агониста рецептора s1p | |
| ES2350103T3 (es) | Asociación de un antagonista o agonista inverso del receptor h3 de la histamina con un antipsicótico o un antidepresivo y su uso para preparar un medicamento que evite los efectos indeseables de los fármacos psicotropos. | |
| BR112020016500A2 (pt) | Agente preventivo ou terapêutico e composição farmacêutica para doença inflamatória ou doença óssea | |
| KR20210074315A (ko) | P2x3 길항제를 사용한 소양증의 치료 | |
| US20130172304A1 (en) | Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual Disorders | |
| JP7151029B2 (ja) | 精神障害の治療における使用のためのイロペリドン代謝物 | |
| JP6784407B2 (ja) | 近視予防剤及び近視進行抑制剤 | |
| JP7281406B2 (ja) | ポネシモドを含有する医薬的組み合わせ | |
| WO2022087176A1 (en) | Administration of antipurinergic compositions for treating nervous system disorders | |
| EP3706744B1 (en) | Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use | |
| RU2008108175A (ru) | Комбинация соединений, которые можно использовать при лечении респираторных заболеваний, особенно хронической оструктивной болезни легких (copo) и астмы | |
| DK2694065T3 (en) | COMPOSITION FOR TREATMENT OF DISORDER WITH SEXUAL SEXUAL LISTENING | |
| WO2024006841A2 (en) | Compositions for weight loss and cancer treatment | |
| KR20190013847A (ko) | 불안 장애를 치료하기 위한 (2S)-1-[4-(3,4-디클로로페닐)피페리딘-1-일]-3-[2-(5-메틸-1,3,4-옥사디아졸-2-일)벤조[b]푸란-4-일옥시]프로판-2-올 또는 그의 대사산물 | |
| RU2008108176A (ru) | Комбинация соединений, которая может быть применена в лечении респеративных заболеваний, особенно хронического обструктивного заболевания легких (copd) и астмы | |
| JP2005531622A5 (cg-RX-API-DMAC7.html) | ||
| HK40071167B (en) | Methods for treating behavioral and psychological symptoms in patients with dementia | |
| US20100227844A1 (en) | Cannabinoid-1 receptor modulators useful for the treatment of alzheimer's disease |